Curative effect of ziprasidone in the treatment of agitation in acute phase of schizophrenia

Abstract

Objective To observe the efficacy and safety of domestic ziprasidone injection in the treatment of excitement and agitation in acute period of schizophrenia. Methods 60 patients with schizophrenia excited were randomly divided into two groups, 30 cases in each group.The treatment group was given ziprasidone 20 to 40mg/day by intramuscular injection, the control group was given haloperidol 10-20mg/day by intramuscular injection, the two groups were observed for three days.The positive and negative symptoms scale(PANSS) in the excitation factor(EC) points rate was used to assess efficacy, symptoms scale(TESS) was used to evaluate the adverse reaction.Before treatment, 2, 6, 24, 48, 72 hours after treatment, the positive and negative symptoms scale of excitement factor(PANSS-EC) and symptoms scale(TESS) were evaluated. Results 72 hours after treatment, the PANSS-EC score in the ziprasidone group was obviously lower, the points rate was (69±18)%, the total effective rate was 83.3%, which of the haloperidol group were (71±26)%, 86.7%, the differences between the two groups were not statistically significant (P>0.05). The incidence of adverse reactions between the ziprasidone group and haloperidol group had no statistically significant difference(P>0.05). But in terms of the incidence of vertebral body system, the ziprasidone group(4 cases) was obviously less than the haloperidol group(13 cases), the difference was statistically significant(χ2=6.65, P<0.05). Conclusion Ziprasidone injection is effective in the treatment of agitation in acute phase of schizophrenia, with less side effect, higher safety. Key words: Ziprasidone; Schizophrenia; Excitement; Agitation